
To evaluate the effectiveness of zzso zzso as compared with zzso in cancer patients with fatigue, as measured by the zzso Assessment for zzso Illness zzso zzso 

Patients with a fatigue score of at least 4 on a scale of 0 to 10 zzso zzso no fatigue, 10 zzso worst possible zzso and zzso level of at least 10 zzso were zzso Patients were randomly assigned to receive 5 zzso zzso or zzso every 2 hours as needed zzso of four capsules a zzso for 7 zzso Patients completed a daily diary including study drug record and fatigue zzso A research nurse telephoned patients daily to assess toxicity and fatigue zzso All patients were offered zzso zzso for 4 zzso zzso and the Edmonton zzso Assessment System zzso were assessed at zzso and days 8, 15, and zzso The zzso fatigue zzso on day 8 was considered the primary end zzso 

Of 112 patients randomly zzso 52 patients in the zzso and 53 in the zzso group were zzso for zzso zzso intensity improved significantly on day 8 in both the zzso and zzso zzso However, there was no significant difference in fatigue improvement by zzso zzso zzso zzso or zzso zzso zzso zzso between zzso In zzso phase, fatigue intensity maintained low as compared with zzso No significant zzso were zzso 

Both zzso and zzso resulted in significant symptom zzso zzso was not significantly superior to zzso after 1 week of zzso zzso study duration is zzso The role of daily telephone calls from a research nurse should be explored as a zzso care zzso 

